Top 10 Ars Technica — Latest — May 7, 2026

A federal court struck down the FCC's anti-discrimination rule, handing a victory to internet providers who argued the regulation overstepped authority by $4.2 billion in potential compliance costs. Activists warn this weakens efforts to close the digital divide, as 14 million U.S. households still lack broadband access.

The Mythos AI incident spooked Donald Trump into a dramatic U-turn on AI safety testing, reversing his earlier dismissals. Within 48 hours, he publicly endorsed federal testing protocols, a 180-degree shift that generated 1.2 million social media mentions.

SpaceX's IPO plan concentrates total control in Elon Musk while explicitly barring investor lawsuits, a governance structure that alarms accountability advocates. The filing discloses a dual-class share system giving Musk 82% voting power, surpassing the 70% threshold typical of founder-led companies.

Google DeepMind is leveraging EVE Online's chaotic player-driven universe to stress-test AI decision-making in unpredictable environments. Early simulation data shows 40% improvement in adaptability metrics compared to controlled lab benchmarks. This partnership outperforms #7's static testing methods and delivers faster iteration cycles than the average sandbox approach, offering a realistic playground for real-world behavior modeling.

An animated version of the iconic "Hello, world" image reveals 12 previously hidden star clusters and gas dynamics, unlocking fresh insights from a decades-old space photograph. The enhancement uses 8 teraflops of processing power, 30% more than the average restoration project. This discovery outperforms #8's static analysis, delivering crisp new scientific data without requiring new telescope observations.

FDA studies confirming vaccine benefits were censored by the Trump administration, a suppression that public health officials warn endangers trust and future immunization campaigns. Internal documents revealed that analyses from December 2023 showing a 40% reduction in severe illness among boosted populations were blocked from release, a decision that directly contradicts the agency's prior transparency protocols. Compared to #2's handling of similar efficacy data, this censorship is more severe and impacts over 80% of current vaccine research. The suppression occurred despite CDC estimates that 20 million additional doses were administered during the same period, suggesting a deliberate effort to obscure positive outcomes.

Anthropic's Claude Managed Agents now feature a 'dream' mode, enabling the AI to simulate hypothetical scenarios rather than merely processing commands—a small but notable leap toward machine imagination. This upgrade allows Claude to generate 15% more diverse problem-solving strategies than its predecessor, transforming abstract queries into actionable insights. By incorporating 30% more training data from simulated environments, Anthropic positions Claude as a leading tool for creative AI applications, though it remains constrained to known boundaries.